Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis

BACKGROUND: Serotonin reuptake inhibitor (SRI) antidepressants are implicated in increasing the risk of bleeding among users; however, the comparative increase in bleeding risk with concurrent antithrombotic therapy (anticoagulant or antiplatelet) remains unclear. As such, we performed a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nochaiwong, Surapon, Ruengorn, Chidchanok, Awiphan, Ratanaporn, Chai-Adisaksopha, Chatree, Tantraworasin, Apichat, Phosuya, Chabaphai, Kanjanarat, Penkarn, Chongruksut, Wilaiwan, Sood, Manish M., Thavorn, Kednapa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Cardiology & Cardiovascular Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725830/
https://www.ncbi.nlm.nih.gov/pubmed/34955074
http://dx.doi.org/10.1080/07853890.2021.2017474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725830/
https://www.ncbi.nlm.nih.gov/pubmed/34955074
http://dx.doi.org/10.1080/07853890.2021.2017474

Ejemplares similares